07 Jan 2001

Lonarid® (Lonarid® Tabletten) - Deutschland

Updated: 07 Jan 2001

Lonarid®

Mittelstarke bis starke Schmerzen. Für Erw. und Jugendl.

Lonarid® Description, Presentation and Dosage

Lonarid® Description

Lonarid® Drug Class Description

Kombinationen mit Codein u. -Derivaten

Lonarid® Drug Description

1 Tbl. enth.: Paracetamol 500 mg, Codeinphosphat ½H2O 30 mg.

Lonarid® Generic Name

Lonarid® Tabletten

Lonarid® Presentation

Lonarid® Presentation

Lonarid®

Lonarid® Manufacturer

Boehringer Ingelheim

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Lonarid® Dosage

Lonarid® Adult Dosage

Cellulose, Carmellose-Natrium, Ethylcellulose, Maisstärke, Siliciumdioxid, Magnesiumstearat.

Lonarid® Precautions, Reactions and Contraindications

Lonarid® Special Precautions

Lonarid® Special Precautions

C 85. Krankheitszustände, bei denen eine Dämpfung des Atemzentrums vermieden werden muß. Kdr. unter 14 J.

Lonarid® Adverse Reactions

Lonarid® Adverse Reactions

C 85, P 5

Related Drugs - Pain Management

Back to top